CHELSEA THORN: Open Payments
NPI 1013451277 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 28 payments from 13 companies in 2025. Trend: 2023 $598 · 2024 $761 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $168 |
| BIOTRONIK NRO, Inc. | 3 | $161 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $78 |
| Abbott Laboratories | 3 | $65 |
| Averitas Pharma Inc. | 1 | $59 |
| Pacira Pharmaceuticals Incorporated | 1 | $35 |
| UCB, Inc. | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| SI-BONE, INC. | 1 | $21 |
| SCILEX PHARMACEUTICALS INC. | 1 | $19 |
Products named: Prospera, BOTOX, RELISTOR, QUTENZA, ETERNA, Zilretta, Rystiggo, PROCLAIM.
Industry payments across KY — which companies pay providers there.
